Evogene Ltd. (TLV: EVGN)
Israel
· Delayed Price · Currency is ILS · Price in ILA471.00
+19.00 (4.20%)
Dec 19, 2024, 5:24 PM IDT
Evogene Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -23.51 | -23.88 | -26.64 | -27.79 | -23.37 | -18.11 | Upgrade
|
| Depreciation & Amortization | 2.57 | 2.61 | 2.58 | 2.23 | 2.73 | 2.77 | Upgrade
|
| Other Amortization | 0.14 | - | - | - | 0.21 | - | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.02 | -0.03 | - | 0.12 | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.5 | - | - | - | - | 0.01 | Upgrade
|
| Stock-Based Compensation | 1.59 | 1.88 | 1.19 | 2.61 | 4.1 | 1.58 | Upgrade
|
| Other Operating Activities | 0.4 | -1.76 | -0.04 | -3.54 | -1.73 | -2.92 | Upgrade
|
| Change in Accounts Receivable | -0.25 | -0.01 | -0.07 | -0.06 | -0.15 | 0.09 | Upgrade
|
| Change in Inventory | -1.34 | 0.49 | -0.47 | -0.09 | - | - | Upgrade
|
| Change in Accounts Payable | 0.03 | 0.74 | -0.47 | 0.63 | -0.03 | -0.12 | Upgrade
|
| Change in Unearned Revenue | -0.57 | -0.29 | -0.15 | 0.13 | -0.34 | -0.05 | Upgrade
|
| Change in Other Net Operating Assets | -0.12 | -1.43 | 0.49 | 1.05 | -0.93 | -0.92 | Upgrade
|
| Operating Cash Flow | -20.42 | -21.58 | -23.68 | -24.72 | -19.51 | -17.67 | Upgrade
|
| Capital Expenditures | -0.39 | -0.79 | -1.17 | -0.85 | -0.68 | -0.9 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.06 | 0.03 | - | - | - | - | Upgrade
|
| Investment in Securities | 0.61 | -3.78 | 14.45 | -19.72 | 10.1 | 38.04 | Upgrade
|
| Investing Cash Flow | 0.28 | -4.54 | 13.27 | -20.57 | 9.42 | 37.14 | Upgrade
|
| Long-Term Debt Repaid | - | -0.84 | -0.8 | -0.58 | -0.64 | -0.6 | Upgrade
|
| Net Debt Issued (Repaid) | -0.91 | -0.84 | -0.8 | -0.58 | -0.64 | -0.6 | Upgrade
|
| Issuance of Common Stock | 5.02 | 8.45 | 0.03 | 30.07 | 18.72 | - | Upgrade
|
| Other Financing Activities | -0.05 | 10.54 | 10.12 | 0.79 | 2.3 | 9.9 | Upgrade
|
| Financing Cash Flow | 4.07 | 18.15 | 9.34 | 30.28 | 20.37 | 9.31 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.06 | -0.25 | -2.28 | 1.1 | 1.21 | 0.16 | Upgrade
|
| Net Cash Flow | -16.01 | -8.21 | -3.35 | -13.9 | 11.48 | 28.94 | Upgrade
|
| Free Cash Flow | -20.81 | -22.36 | -24.85 | -25.56 | -20.2 | -18.57 | Upgrade
|
| Free Cash Flow Margin | -278.26% | -396.49% | -1483.52% | -2748.71% | -1941.92% | -2465.60% | Upgrade
|
| Free Cash Flow Per Share | -3.97 | -4.89 | -6.03 | -6.32 | -7.17 | -7.21 | Upgrade
|
| Cash Interest Paid | 0.08 | 0.12 | 0.17 | 0.32 | 0.24 | 0.3 | Upgrade
|
| Cash Income Tax Paid | 0.02 | 0.03 | 0.04 | 0.01 | 0.01 | 0.02 | Upgrade
|
| Levered Free Cash Flow | 2.08 | -12.6 | -14.89 | -17.97 | -6.7 | -11.68 | Upgrade
|
| Unlevered Free Cash Flow | 3.59 | -12.52 | -14.78 | -17.77 | -6.55 | -11.49 | Upgrade
|
| Change in Net Working Capital | -15.16 | -0.34 | 0.54 | 2.42 | -2.61 | 1.71 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.